GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Lifesciences | Healthcare & Wellness

GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028

Market by Drug Class, Application, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research predicts that the global market for dermatological therapeutics would witness a CAGR of 7.90% over the forecast period 2019-2028. The market was assessed to be worth $24.69 billion in the year 2019, and is predicted to generate a revenue of approximately $48.94 million by the year 2028.


Report scope can be customized per your requirements. Request For Customization

Dermatological therapeutics has witnessed stable growth owing to the rising burden of dermatological diseases. Dermatological therapeutics deals with the treatment and prevention of the diseases of the skin, hairs, nails, genitals, and oral cavities.



Triton Market Research’s report on the dietary supplements market provides an in-depth insight into the market. The detailed analysis of the market includes key market insights, Porter’s five forces analysis, and market attractiveness index.

Key drivers such as the rise in skin diseases and increasing awareness towards disease prognosis are fueling the market demand. According to the Global Burden of Disease (GBD), acne vulgaris affects about 84% of adolescents aged between 12–25 years. Acne consistently represents the topmost prevalent skin conditions in the general population, as found in large studies within the United Kingdom, France, and the United States. In recent years, due to a better understanding of the pathogenesis of acne and other therapeutics, the market is gaining traction.

Moreover, in developing countries such as India, several studies have been published on skin diseases that showcase that the rising skin diseases in the rural sector, paired with the low level of sanitation, is among the primary reasons for the large number of skin diseases prevalent today, such as seborrhea capitis, acne vulgaris, tinea, pityriasis versicolor, and scabies. Such factors are propelling the growth of the overall market.

However, despite skin treatments, there are certain major side-effects associated with corticosteroids, anti-infectives, anti-acne, retinoids, and every other drug class, which are quite prominent than others. Such side-effects have some grave negative implications on the health and lifestyle, which could strain in the dermatological therapeutics market.

Key geographies covered in the global dermatological therapeutics market are:

•           North America: United States and Canada

•           Europe: United Kingdom, France, Germany, Spain, Italy, Russia, and Rest of Europe

•           Asia-Pacific: China, Japan, India, Australia, South Korea, ASEAN Countries, and Rest of Asia-Pacific

•           Latin America: Brazil, Mexico, and Rest of Latin America

•           Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East & Africa

The segmentation analysis of the dermatological therapeutics market includes:

•           Market by Drug Class:

O         Anti-infectives

O         Corticosteroids

O         Anti-acne

O         Calcineurin Inhibitors

O         Retinoids

O         Other Drug Classes

•           Market by Application:

O         Alopecia

O         Herpes

O         Psoriasis

O         Rosacea

O         Atopic Dermatitis

O         Acne Vulgaris

O         Other Applications

The key companies profiled in the report include AGI Dermatics, Allergan, Abbvie Inc, Amgen Inc, Almirall, Pfizer Inc, Johnson & Johnson, Bausch Health Companies Inc, Glaxosmithkline Plc, Galderma, Novartis AG, Merck & Co, and Leo Pharma A/S.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   ASIA-PACIFIC IS MOST ENCOURAGING REGIONAL MARKET

2.2.2.   CHINA IS LEADING OVERALL MARKET

2.2.3.   ADVANCEMENTS IN BIOLOGICS

2.2.4.   ATOPIC DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF SUPPLIERS

2.3.4.   BARGAINING POWER OF BUYERS

2.3.5.   THREAT OF COMPETITIVE RIVALRY

2.4. IMPACT OF COVID-19 – DERMATOLOGICAL THERAPEUTICS

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. MARKET DRIVERS

2.7.1.   INCREASING BURDEN OF DERMATOLOGICAL DISEASES

2.8. MARKET RESTRAINTS

2.8.1.   GRAVE SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS

2.9. MARKET OPPORTUNITIES

2.9.1.   RISE IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION

2.10. MARKET CHALLENGES

2.10.1. UNAWARENESS TOWARDS DERMATOLOGICAL DIAGNOSIS

3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY DRUG CLASS

3.1. ANTI-INFECTIVES

3.2. CORTICOSTEROIDS

3.3. ANTI-ACNE

3.4. CALCINEURIN INHIBITORS

3.5. RETINOIDS

3.6. OTHER DRUG CLASSES

4. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION

4.1. ALOPECIA

4.2. HERPES

4.3. PSORIASIS

4.4. ROSACEA

4.5. ATOPIC DERMATITIS

4.6. ACNE VULGARIS

4.7. OTHER APPLICATIONS

5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK

5.1. NORTH AMERICA

5.1.1.   MARKET BY DRUG CLASS

5.1.2.   MARKET BY APPLICATION

5.1.3.   COUNTRY ANALYSIS

5.1.3.1. UNITED STATES

5.1.3.2. CANADA

5.2. EUROPE

5.2.1.   MARKET BY DRUG CLASS

5.2.2.   MARKET BY APPLICATION

5.2.3.   COUNTRY ANALYSIS

5.2.3.1. UNITED KINGDOM

5.2.3.2. GERMANY

5.2.3.3. FRANCE

5.2.3.4. SPAIN

5.2.3.5. ITALY

5.2.3.6. RUSSIA

5.2.3.7. REST OF EUROPE

5.3. ASIA-PACIFIC

5.3.1.   MARKET BY DRUG CLASS

5.3.2.   MARKET BY APPLICATION

5.3.3.   COUNTRY ANALYSIS

5.3.3.1. CHINA

5.3.3.2. JAPAN

5.3.3.3. INDIA

5.3.3.4. SOUTH KOREA

5.3.3.5. ASEAN COUNTRIES

5.3.3.6. AUSTRALIA & NEW ZEALAND

5.3.3.7. REST OF ASIA-PACIFIC

5.4. LATIN AMERICA

5.4.1.   MARKET BY DRUG CLASS

5.4.2.   MARKET BY APPLICATION

5.4.3.   COUNTRY ANALYSIS

5.4.3.1. BRAZIL

5.4.3.2. MEXICO

5.4.3.3. REST OF LATIN AMERICA

5.5. MIDDLE EAST AND AFRICA

5.5.1.   MARKET BY DRUG CLASS

5.5.2.   MARKET BY APPLICATION

5.5.3.   COUNTRY ANALYSIS

5.5.3.1. UNITED ARAB EMIRATES

5.5.3.2. TURKEY

5.5.3.3. SAUDI ARABIA

5.5.3.4. SOUTH AFRICA

5.5.3.5. REST OF MIDDLE EAST & AFRICA

6. COMPETITIVE LANDSCAPE

6.1. ABBVIE INC

6.2. ALLERGAN

6.3. ALMIRALL

6.4. AMGEN INC

6.5. BAUSCH HEALTH COMPANIES INC

6.6. GALDERMA

6.7. GLAXOSMITHKLINE PLC

6.8. JOHNSON & JOHNSON

6.9. NOVARTIS AG

6.10. PFIZER INC

6.11. AGI DERMATICS

6.12. LEO PHARMA A/S

6.13. MERCK & CO

7. METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of table

TABLE 1: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, 2019-2028 (IN $ BILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 5: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

TABLE 6: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY GEOGRAPHY, 2019-2028 (IN $ BILLION)

TABLE 7: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 8: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 9: NORTH AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

TABLE 10: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 11: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 12: EUROPE DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

TABLE 13: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 14: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 15: ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

TABLE 16: LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 17: LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 18: LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)

TABLE 19: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)

TABLE 20: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)

TABLE 21: MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $ BILLION)

FIGURE 3: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ BILLION)

FIGURE 4: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)

FIGURE 5: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ BILLION)

FIGURE 6: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)

FIGURE 7: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $ BILLION)

FIGURE 8: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)

FIGURE 9: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)

FIGURE 10: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $ BILLION)

FIGURE 11: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $ BILLION)

FIGURE 12: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS 2019-2028 (IN $ BILLION)

FIGURE 13: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $ BILLION)

FIGURE 14: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ BILLION)

FIGURE 15: GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 16: UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 17: CANADA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 18: UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 19: GERMANY DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 20: FRANCE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 21: SPAIN DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 22: ITALY DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 23: RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 24: REST OF EUROPE DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 25: CHINA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 26: JAPAN DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 27: INDIA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 28: SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 29: ASEAN COUNTRIES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 30: AUSTRALIA & NEW ZEALAND DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 31: REST OF ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 32: BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 33: MEXICO DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 34: REST OF LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 35: UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 36: TURKEY DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 37: SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 38: SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

FIGURE 39: REST OF MIDDLE EAST AND AFRICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;